» Articles » PMID: 18418275

Tumor Volume As a Prognostic Factor in Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy

Overview
Journal Laryngoscope
Date 2008 Apr 18
PMID 18418275
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives/hypothesis: Tumor volume has been demonstrated to play a prognostic role in many head and neck cancers. The purpose of this study was to conduct an institutional review analyzing the correlation between tumor volume and locoregional control of oropharyngeal squamous cell cancer treated with primary radiotherapy.

Study Design: Retrospective institutional chart analysis.

Methods: Seventy-nine patients from 1991 to 2005 with primary T1 to T4 oropharyngeal squamous cell carcinoma (base of tongue, n = 31; soft palate, n = 1; tonsils, n = 47) were treated with primary radiotherapy. Tumor volumes were measured from pretreatment computerized tomography scans by two observers. Three-dimensional tumor volumes were calculated using a computer digitizer for each computed tomography slice showing the primary lesion. Survival analysis, using the methods of Kaplan and Meier, was performed to assess whether tumor volume, Tumor, Node, Metastasis classification, tumor stage, or location were associated with locoregional failure.

Results: Tumor volume did not significantly correlate with locoregional failure (observer 1, P = .6244; observer 2, P = .5612). There was a high interobserver correlation (r = 0.98970). Univariate analysis did, however, demonstrate a significant difference in locoregional failure between T4 tumors and all other T stages (T1 vs. T4, P = .0107; T2 vs. T4, P = .0004; T3 vs. T4, P = .0155). Nodal status, tumor stage, and location did not significantly correlate with locoregional failure rate.

Conclusions: Tumor volume does not appear to play a significant role in predicting locoregional recurrence for patients with primary squamous cell cancer of the oropharynx treated with primary radiotherapy. However, T4 status was predictive of poor locoregional control.

Citing Articles

Pretreatment Tumor Volume and Tumor Sphericity as Prognostic Factors in Patients with Oral Cavity Squamous Cell Carcinoma: A Prospective Clinical Study in 95 Patients.

Lucchi E, Cercenelli L, Maiolo V, Bortolani B, Marcelli E, Tarsitano A J Pers Med. 2023; 13(11).

PMID: 38003916 PMC: 10672547. DOI: 10.3390/jpm13111601.


The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.

Sjoblom A, Carpen T, Stenman U, Jouhi L, Haglund C, Syrjanen S Cancers (Basel). 2022; 14(12).

PMID: 35740496 PMC: 9221036. DOI: 10.3390/cancers14122830.


Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy.

Adrian G, Carlsson H, Kjellen E, Sjovall J, Zackrisson B, Nilsson P Radiat Oncol. 2022; 17(1):107.

PMID: 35701827 PMC: 9195357. DOI: 10.1186/s13014-022-02074-7.


Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis.

Russo E, Accorona R, Iocca O, Costantino A, Malvezzi L, Ferreli F Cancers (Basel). 2022; 14(10).

PMID: 35626068 PMC: 9139846. DOI: 10.3390/cancers14102465.


The Epithelial-Mesenchymal Transcription Factor Slug Predicts Survival Benefit of Up-Front Surgery in Head and Neck Cancer.

Riechelmann H, Steinbichler T, Sprung S, Santer M, Runge A, Ganswindt U Cancers (Basel). 2021; 13(4).

PMID: 33673269 PMC: 7918715. DOI: 10.3390/cancers13040772.